Pila Pharma AB
Save
OverviewDividend safetyDividendsFundamentals
94.67M
Market cap
–
Current P/E
–
Forward P/E

About

Health care
Sector
Biotechnology
Industry

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Similar securities

Based on sector and market capitalization

ScandiDos AB
Kontigo Care AB
ISR Immune System Regulation Holding AB (publ)
Medhelp Care AB
Scibase AB
Newbury Pharmaceuticals AB
Report issue